2,8-Diacetylamino-1-tetralone → 2-Acetylamino-8-amino-5-methyl-1-tetralone
반응식
[C:1]([NH:4][CH:5]1[CH2:14][CH2:13][C:12]2[C:7](=[C:8]([NH:16]C(=O)C)[CH:9]=[CH:10][C:11]=2[CH3:15])[C:6]1=[O:20])(=[O:3])[CH3:2].C(NC1CCC2C(=C(NC(=O)C)C=CC=2)C1=O)(=O)C>>[C:1]([NH:4][CH:5]1[CH2:14][CH2:13][C:12]2[C:7](=[C:8]([NH2:16])[CH:9]=[CH:10][C:11]=2[CH3:15])[C:6]1=[O:20])(=[O:3])[CH3:2]참가 물질
3
실험 절차
The reaction was carried out in the same manner as in Example 1-(4), except that 400 mg of the compound prepared in (7) above was used instead of 2,8-diacetylamino-1-tetralone of Example 1-(4), and post-treated to produce 265 mg of the title compound.
후처리
- additionpost-treated
출처 및 근거
- ORD 기록
- ord-5c36ab79f2e04e778313519007891dd5
- 출처 데이터셋
- uspto-grants-1998_11
- 특허 번호
- US05834476
반응 노트
불러오는 중…